Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
FITC-Concanavalin A (ConA) Guide
2026-09-02
FITC-Concanavalin A (ConA) Conjugate provides direct fluorescent detection of α-D-glucose and α-D-mannose residues on glycoproteins and glycolipids. It is appropriate for cell surface carbohydrate detection, immunofluorescence staining, tissue staining, and flow cytometry, but it should not be interpreted as a marker for a specific protein or used outside carbohydrate-binding applications.
-
Ceftazidime as a Phenotypic Lens on Resistance
2026-09-02
Ceftazidime is more than a third-generation cephalosporin benchmark: it can help connect antimicrobial phenotype, carbapenemase genetics, and plasmid mobility. This article presents an assay-first framework grounded in recent CREC surveillance research.
-
Bicinchoninic Acid Assay (BCA) Kit
2026-09-01
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 measures low-concentration total protein in dilute biochemical samples, including many detergent-containing preparations and cell lysates. It is intended for scientific research workflows such as sample normalization, not diagnostic, clinical, or medical testing.
-
L-Ornithine, OTC, and Realgar CNS Toxicity
2026-09-01
A 2025 Advanced Science study identifies a liver–brain mechanism in realgar-induced neurotoxicity: hepatic OTC inhibition increases ornithine, while arsenic and ornithine converge on astrocytic ZBTB7A to suppress glycolysis. The work connects altered urea-cycle metabolism with frontal-lobe energy failure and provides a framework for integrating metabolic, transcriptomic, and neurobehavioral measurements.
-
Aβ42 Beyond Plaques: Translational Research Strategy
2026-08-31
Amyloid β-Peptide (1-42) is more than a plaque-forming species: its aggregation state can shape neuronal toxicity, ion-channel behavior, and microglial clearance signaling. This thought-leadership guide connects those mechanisms to reproducible assay design and translational decision-making.
-
BCA Protein Quantification Kit: Practical Guide
2026-08-31
The BCA Protein Quantification Kit (SKU K4102) provides sensitive total-protein measurement for dilute samples, including many detergent-containing biochemical preparations and cell lysates. It is intended for scientific research use only and should not be used for diagnostic, clinical, or medical testing.
-
Imatinib in Gastric Cancer Assembloid Research
2026-08-30
A translational framework for using Imatinib (STI571) to connect kinase pharmacology with patient-derived gastric cancer assembloids, stromal biology, and more predictive drug-response studies.
-
ATRX Loss and RTK Inhibitor Sensitivity in Glioma
2026-08-29
The reference study identifies ATRX deficiency as a vulnerability that increases the sensitivity of high-grade glioma cells to multi-targeted receptor tyrosine kinase and PDGFR inhibitors. Its combination data further suggest that ATRX status could help interpret RTK inhibitor trials and guide temozolomide-based treatment strategies.
-
Ruthenium Ratiometric Imaging of Amyloid-β Fibrils
2026-08-28
The 2024 Inorganic Chemistry study introduced dual-emissive tris-heteroleptic Ru(II) complexes for ratiometric detection and confocal imaging of amyloid-β fibrils. Complex 2 combined a stable fluorescence reference with an aggregation-responsive phosphorescence signal, improving interpretability while revealing stronger apparent interactions with Aβ40 fibrils than with Aβ42 fibrils.
-
Amyloid Beta-peptide (25-35): Assay Design
2026-08-28
Amyloid Beta-peptide (25-35) and Aβ25-35 are powerful tools for modeling amyloid-driven neuronal injury. This guide advances beyond endpoint cytotoxicity by showing how to connect peptide exposure with microglial signaling, neuroinflammation, and mechanism-resolved assay decisions.
-
Recombinant Mouse IFN-γ in MASH-HCC Assays
2026-08-27
Use Recombinant Mouse IFN-γ as a controlled stimulus to distinguish defective cytokine signaling from bile acid–driven antigen-presentation failure in MASH-HCC models. This workflow combines dose-response testing, MHC-I readouts, and immune-cell validation while preserving the product’s antiviral assay benchmark.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-08-27
FITC-Concanavalin A (ConA) Conjugate is a fluorescent lectin conjugate for detecting α-D-glucose and α-D-mannose moieties on glycoproteins and glycolipids in cell and tissue samples. It supports immunofluorescence staining and flow cytometry carbohydrate analysis, but should not be used as a general membrane stain, antibody substitute, or probe for non-carbohydrate targets.
-
Oleanolic Acid: From Lipophilic Cargo to Assay Design
2026-08-26
Oleanolic acid is a lipophilic triterpenoid whose inducible nitric oxide synthase induction makes it relevant to immune and antiviral research. This article shows how its physicochemical behavior and nanoparticle exclusion chromatography can improve dual-loaded liposome assay decisions.
-
QPRT, P2Y11, and Breast Cancer Invasion
2026-08-26
The reference study connects elevated quinolinate phosphoribosyltransferase (QPRT) with breast cancer cell migration and invasion, identifying myosin light chain phosphorylation as a functional endpoint. Its genetic and pharmacological experiments implicate P2Y11-linked purinergic signaling as an important mechanistic route, while also defining limitations that matter for translating this model into cancer research.
-
Amyloid Beta-Peptide (1-40): Fibril Assay Guide
2026-08-25
Build reproducible Aβ40 aggregation, imaging, and neurotoxicity workflows with a defined human peptide standard. A ratiometric ruthenium-probe strategy adds state-sensitive fibril detection beyond conventional single-channel fluorescence.